Literature DB >> 9927064

Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human papillary thyroid carcinomas.

H Nakamura1, H Ueno, K Yamashita, T Shimada, E Yamamoto, M Noguchi, N Fujimoto, H Sato, M Seiki, Y Okada.   

Abstract

Matrix metalloproteinases (MMPs) are believed to be involved in the invasion and metastasis of various human carcinomas. In the present study, the production levels of seven different MMPs (MMP-1, -2, -3, -7, -8, -9, and -13), the activation of the zymogen of MMP-2 (proMMP-2), the expression of membrane-type MMPs (MT1-, MT2-, and MT3-MMPs), and the tissue localization of the activated enzyme were examined in human invasive papillary thyroid carcinomas. Sandwich enzyme immunoassays revealed that among the MMPs examined, only the MMP-2 production level is significantly enhanced in the carcinoma tissues compared with the follicular adenoma and normal control thyroid tissues. Gelatin zymography indicated that the proMMP-2 activation ratio is considerably higher in carcinomas with lymph node metastasis than it is in those without metastasis, follicular adenomas, or normal controls (P < 0.01). Northern blot analysis of the expression of MT1-, MT2-, and MT3-MMPs, which are known to activate proMMP-2 in vitro, demonstrated the predominant expression of MT1-MMP mRNA in the carcinoma tissues (15 of 15 cases), whereas MT2-MMP expression was confined to 26% of the cases (4 of 15 cases), and no consistent expression of MT3-MMP was observed. MTI-MMP mRNA expression levels correlated with the proMMP-2 activation ratio (r = 0.692; P < 0.01), but such a correlation was not obtained with MT2-MMP. There was also a direct correlation between MT1-MMP expression and lymph node metastasis (P < 0.05). In situ hybridization indicated that both carcinoma and stromal cells express MT1-MMP transcripts (five of six cases). MT1-MMP was also immunolocalized to carcinoma and stromal cells in all of the carcinoma samples (26 of 26 cases), which were positive for MMP-2. In situ zymography indicated definite gelatinolytic activity in the carcinoma cell nests, which was abolished by incubation of the carcinoma samples with a synthetic MMP inhibitor before the reaction. These results suggest for the first time that among seven different MMPs, the production of proMMP-2 and its MT1-MMP-mediated activation in the carcinoma cell nests play an important role in the lymph node metastasis of human invasive papillary thyroid carcinomas.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 9927064

Source DB:  PubMed          Journal:  Cancer Res        ISSN: 0008-5472            Impact factor:   12.701


  26 in total

1.  Expression of matrix metalloproteinases in invasive pulmonary adenocarcinoma with bronchioloalveolar component and atypical adenomatous hyperplasia.

Authors:  F Kumaki; K Matsui; T Kawai; Y Ozeki; Z X Yu; V J Ferrans; W D Travis
Journal:  Am J Pathol       Date:  2001-12       Impact factor: 4.307

2.  Targeted deletion or pharmacological inhibition of MMP-2 prevents cardiac rupture after myocardial infarction in mice.

Authors:  Shin-ichiro Matsumura; Shiro Iwanaga; Satsuki Mochizuki; Hiroyuki Okamoto; Satoshi Ogawa; Yasunori Okada
Journal:  J Clin Invest       Date:  2005-03       Impact factor: 14.808

3.  Targeting the MMP-14/MMP-2/integrin αvβ3 axis with multispecific N-TIMP2-based antagonists for cancer therapy.

Authors:  Gal Yosef; Valeria Arkadash; Niv Papo
Journal:  J Biol Chem       Date:  2018-07-09       Impact factor: 5.157

4.  Enhanced production and activation of progelatinase A mediated by membrane-type 1 matrix metalloproteinase in human oral squamous cell carcinomas: implications for lymph node metastasis.

Authors:  T Shimada; H Nakamura; K Yamashita; R Kawata; Y Murakami; N Fujimoto; H Sato; M Seiki; Y Okada
Journal:  Clin Exp Metastasis       Date:  2000       Impact factor: 5.150

5.  Matrix metalloproteinase (MMP) expression by differentiated thyroid carcinoma of children and adolescents.

Authors:  A Patel; A M Straight; H Mann; E Duffy; C Fenton; C Dinauer; R M Tuttle; G L Francis
Journal:  J Endocrinol Invest       Date:  2002-05       Impact factor: 4.256

6.  Targeting a single function of the multifunctional matrix metalloprotease MT1-MMP: impact on lymphangiogenesis.

Authors:  Signe Ingvarsen; Astrid Porse; Charlotte Erpicum; Ludovic Maertens; Henrik J Jürgensen; Daniel H Madsen; Maria C Melander; Henrik Gårdsvoll; Gunilla Høyer-Hansen; Agnès Noel; Kenn Holmbeck; Lars H Engelholm; Niels Behrendt
Journal:  J Biol Chem       Date:  2013-02-14       Impact factor: 5.157

7.  Expression of MT1-MMP during deciduous tooth resorption in odontoclasts.

Authors:  Busayarat Linsuwanont-Santiwong; Yuzo Takagi; Keiichi Ohya; Hitoyata Shimokawa
Journal:  J Bone Miner Metab       Date:  2006       Impact factor: 2.626

8.  Differences between scirrhous and non-scirrhous human gastric carcinomas from the aspect of proMMP-2 activation regulated by TIMP-3.

Authors:  Takeyoshi Yokoyama; Hiroyuki Nakamura; Yoshihide Otani; Tetsuro Kubota; Noboru Fujimoto; Motoharu Seiki; Masaki Kitajima; Yasunori Okada
Journal:  Clin Exp Metastasis       Date:  2004       Impact factor: 5.150

9.  Tissue inhibitor of matrix metalloproteinase-2 in nasopharyngeal carcinoma.

Authors:  Amr Ahmed El Badry; Amal Abou El-Fadle; Abdel Latif El-Balshy
Journal:  MedGenMed       Date:  2007-07-03

10.  Cell-surface processing of the metalloprotease pro-ADAMTS9 is influenced by the chaperone GRP94/gp96.

Authors:  Bon-Hun Koo; Suneel S Apte
Journal:  J Biol Chem       Date:  2009-10-29       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.